A new scientific journey with empathy for the human one.
Empath Biosciences draws inspiration from nature's molecular diversity to discover novel chemistry from exceptional microbes and engineer new therapies that address critical unmet medical needs. We remain grounded in our mission to innovate for those we serve.
While the complex architecture of natural products has evolved to be potent and selective of their target, most did not evolve from optimization in humans.
But modern advances in molecular biology and bioengineering have made it possible to now efficiently discover and structurally modify promising natural product scaffolds to create safe, effective therapies more efficiently.
Most of the world’s known microbes are under-characterized, but it is estimated that a trillion of the Earth’s bacteria remain undiscovered. Empath derisks drug-hunting with a proprietary database of high-quality genomes of talented organisms from competitive environments.
mHTS is revolutionized with Empath’s proprietary multiplexing activity metabolomics platform which simultaneously evaluates the activity of 1000s of compounds (prior to compound isolation) with unprecedented insight and speed.
Leads that emerge from mHTS can be further optimized for human pharmacology with a full array of modern bioengineering tools available.
Join us as we explore the depths of discovery.
